Delphine Le Corre

6.5k citations

33 papers · 4.7k indexed · 2 hit papers · h-index 16

Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 13
- Colorectal Cancer Screening and Detection 3
Cancer Research top 1%
- Cancer Genomics and Diagnostics 14
Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 12
Hepatology top 2%
Transplantation top 5%
Pulmonary and Respiratory Medicine
- Lung Cancer Treatments and Mutations 5
- Gastric Cancer Management and Outcomes 3
Biomedical Engineering
- Innovative Microfluidic and Catalytic Techniques Innovation 3
Molecular Biology
- Prion Diseases and Protein Misfolding 2

Co-authors: Pierre Laurent‐Puig Bruno Landi Jean‐François Emile Valérie Boige Michel Ducreux Astrid Lièvre Jean‐Baptiste Bachet Philippe Rougier
Cited by: Oncology Cancer Research Pathology and Forensic Medicine
Partner nations: France Germany Italy

In The Last Decade

Delphine Le Corre

32 papers receiving 4.6k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2008 KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab
2006 KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

Peers

Countries citing papers authored by Delphine Le Corre

Since Specialization

Citations

This map shows the geographic impact of Delphine Le Corre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delphine Le Corre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delphine Le Corre more than expected).

Fields of papers citing papers by Delphine Le Corre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delphine Le Corre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delphine Le Corre. The network helps show where Delphine Le Corre may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Delphine Le Corre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Delphine Le Corre Line = papers co-authored together Delphine Le Corre links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ERBB2 Comprehensive Profiling and Prognostication in Stage III Colon Cancer: Findings From PETACC8 and IDEA-France Cohorts Camilla Pilati,Audrey Soulabaille,Claire Gallois,Hélène Blons,Anne Cayre,Marine Sroussi,Delphine Le Corre,Sophie Mouillet‐Richard,Claire Mulot,Karine Le Malicot,Aurélien de Reyniès,Jean‐Baptiste Bachet,Christophe Borg,Frédéric Di Fiore,Rosine Guimbaud,Jaafar Bennouna,Thierry André,Julien Taı̈eb,Frédérique Penault‐Llorca,Pierre Laurent‐Puig	2024	1
2	BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma Raëf Abdallah,Shulin Zhao,Simon Garinet,Katia Hormigos,Delphine Le Corre,Jérôme Cros,Karla Perez‐Toralla,Anne‐Sophie Bats,Jérémy Augustin,Jean‐Baptiste Bachet,Valérie Taly,Hélène Blons,Julien Taı̈eb,Pierre Laurent‐Puig	2022	4
3	A proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer Sophie Mouillet‐Richard,Severine Martin‐Lannerée,Delphine Le Corre,Théo Z. Hirsch,Alexandre Ghazi,Marine Sroussi,Camilla Pilati,Aurélien de Reyniès,Fatima Djouadi,Nicolas Vodovar,Jean‐Marie Launay,Pierre Laurent‐Puig	2022	8
4	Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy Claire Gallois,Julien Taı̈eb,Delphine Le Corre,Karine Le Malicot,Josep Tabernero,Claire Mulot,Jean‐François Seitz,Thomas Aparicio,Gunnar Folprecht,Côme Lepage,Enrico Mini,Jean‐Luc Van Laethem,Jean‐François Emile,Pierre Laurent‐Puig	2018	24
5	ERBB3-Activating Mutations in Small Bowel Adenocarcinomas Luc Cabel,Thomas Aparicio,Ivan Bièche,Magali Svrcek,Aziz Zaanan,Pauline Afchain,Frédéric Di Fiore,Jean‐Marc Gornet,Delphine Le Corre,Sophie Vacher,Céline Callens,Virginie Bernard,Pierre Laurent‐Puig,François‐Clément Bidard	2018	1
6	Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy Claire Gallois,Julien Taı̈eb,Delphine Le Corre,Karine Le Malicot,Josep Tabernero,Claire Mulot,J. F. Seitz,Thomas Aparicio,Gunnar Folprecht,Christian Lepage,Enrico Mini,J.-L. Van Laethem,JF Émile,Pierre Laurent‐Puig	2017	7
7	Real-Time and Non-invasive Monitoring of the Activation of the IRE1α-XBP1 Pathway in Individuals with Hemodynamic Impairment Baptiste Fohlen,Quentin Tavernier,T.M. Huynh,Cédric Caradeuc,Delphine Le Corre,Gildas Bertho,Bernard Cholley,Nicolas Pallet	2017	11
8	Whole exome sequencing (WES) and RNA sequencing (RNA-seq) in routine clinical practice for colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) patients (pts) Géraldine Perkins,Elizabeth Fabre,Vincent Fallet,Hélène Blons,Nicolas Pécuchet,V. Gounant,Laure Gibault,E. Michel-Jeljeli,Martine Antoine,Étienne Roux,Marie Wislez,Delphine Le Corre,Karen Leroy,Roger Lacave,Julien Taı̈eb,Jacques Cadranel,Pierre Laurent‐Puig	2016	0
9	Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium Bastiaan B.J. Tops,Nicola Normanno,Henriette Kurth,Eliana Amato,Andrea Mafficini,Nora Rieber,Delphine Le Corre,Anna Maria Rachiglio,Anne Reiman,Orla Sheils,Christoph Noppen,Ludovic Lacroix,Ian A. Cree,Aldo Scarpa,Marjolijn J. L. Ligtenberg,Pierre Laurent‐Puig	2015	40
10	Clinical Relevance of KRAS -Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy Pierre Laurent‐Puig,Deniz Pekin,Corinne Normand,Steve K. Kotsopoulos,Philippe Nizard,Karla Perez‐Toralla,R. Kevin Rowell,Jeff Olson,Preethi Srinivasan,Delphine Le Corre,Thévy Hor,Zakaria El Harrak,Xinyu Li,Darren R. Link,Olivier Bouché,Jean‐François Emile,Bruno Landi,Valérie Boige,J. Brian Hutchison,Valérie Taly	2014	118
11	ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma A. Laforest,Thomas Aparicio,Aziz Zaanan,Fábio Pittella Silva,Audrey Didelot,A. Desbeaux,Delphine Le Corre,Léonor Benhaïm,Karine Pallier,Daniela E. Aust,Steffen Pistorius,Hélène Blons,Magali Svrcek,Pierre Laurent‐Puig	2014	72
12	Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples Audrey Didelot,Delphine Le Corre,Armelle Luscan,Aurélie Cazes,Karine Pallier,Jean‐François Emile,Pierre Laurent‐Puig,Hélène Blons	2012	91
13	Influence of Cyclooxygenase-2 (COX-2) Gene Promoter Polymorphism −765 on Graft Loss After Renal Transplantation Cécile Courivaud,Jamal Bamoulid,Alexandre Loupy,Marina Deschamps,Christophe Ferrand,Delphine Le Corre,Pierre Tiberghien,J.M. Chalopin,Christophe Legendre,Éric Thervet,Philippe Saas,(unknown)	2009	8
14	KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximabbreakdown → Astrid Lièvre,Jean‐Baptiste Bachet,Valérie Boige,Anne Cayre,Delphine Le Corre,Emmanuel Buc,Marc Ychou,Olivier Bouché,Bruno Landi,Christophe Louvet,Thierry André,Frédéric Bibeau,Marie-Danièle Diébold,Philippe Rougier,Michel Ducreux,Gorana Tomasic,Jean‐François Emile,Frédérique Penault–Llorca,Pierre Laurent‐Puig	2008	1141
15	Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma Hélène Blons,Karine Pallier,Delphine Le Corre,Claire Danel,Maxime Tremblay‐Gravel,Claude Houdayer,Élizabeth Fabre-Guillevin,Marc Riquet,Philippe Dessen,Pierre Laurent‐Puig	2008	31
16	Epidermal Growth Factor Receptor Mutation in Lung Cancer are Linked to Bronchioloalveolar Differentiation Hélène Blons,Jean‐François Côté,Delphine Le Corre,Marc Riquet,Elizabeth Fabre-Guillevin,Pierre Laurent‐Puig,Claire Danel	2006	76
17	Genetic polymorphisms of MMP1, MMP3 and MMP7gene promoter and risk of colorectal adenoma Astrid Lièvre,Jacqueline Milet,Jérôme Carayol,Delphine Le Corre,Chantal Milan,Alexandre Pariente,Bernard Nalet,Jacques Lafon,Jean Faivre,Claire Bonithon‐Kopp,Sylviane Olschwang,Catherine Bonaïti‐Pellié,Pierre Laurent‐Puig,(unknown)	2006	62
18	KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancerbreakdown → Astrid Lièvre,Jean‐Baptiste Bachet,Delphine Le Corre,Valérie Boige,Bruno Landi,Jean‐François Emile,Jean‐François Côté,Gorana Tomasic,Christophe Penna,Michel Ducreux,Philippe Rougier,Frédérique Penault‐Llorca,Pierre Laurent‐Puig	2006	1729
19	Consequences of Genetic Polymorphisms for Sirolimus Requirements After Renal Transplant in Patients on Primary Sirolimus Therapy Dany Anglicheau,Delphine Le Corre,Sophie Lechaton,Pierre Laurent‐Puig,Henri Kreis,Philippe Beaune,Christophe Legendre,Éric Thervet	2005	107
20	Rapamycin inhibits human renal epithelial cell proliferation: Effect on cyclin D3 mRNA expression and stability Nicolas Pallet,Éric Thervet,Delphine Le Corre,Bertrand Knebelmann,Patrick Nusbaum,Céline Tomkiewicz,P. Méria,Jean-Pierre Flinois,Philippe Beaune,Christophe Legendre,Dany Anglicheau	2005	52

About Delphine Le Corre

Delphine Le Corre is a scholar working on Cancer Research, Oncology and Transplantation, having authored 33 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (14 papers), Colorectal Cancer Treatments and Studies (13 papers), Genetic factors in colorectal cancer (12 papers), Lung Cancer Treatments and Mutations (5 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), Colorectal Cancer Screening and Detection (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Prion Diseases and Protein Misfolding (2 papers). The work is most often cited by research in Oncology (3.0k citations), Cancer Research (1.3k citations) and Pathology and Forensic Medicine (1.3k citations). Delphine Le Corre has collaborated with scholars based in France, Germany and Italy. Frequent co-authors include Pierre Laurent‐Puig, Bruno Landi, Jean‐François Emile, Valérie Boige, Michel Ducreux, Astrid Lièvre, Jean‐Baptiste Bachet, Philippe Rougier, Gorana Tomasic and Jean‐François Côté.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact